论文部分内容阅读
目的:分析硝普钠在治疗急性心力衰竭中的疗效及安全性,为临床提供参考资料。方法:选取我院心内科收治的140例急性心力衰竭患者的临床资料。将患者分为对照组75例(2010年6月～2011年6月入院,给予常规治疗);治疗组65例(2011年7月～2012年6月入院,以硝普钠辅助常规治疗),疗程7天。结果:治疗组显效55例,有效15例,无效3例,死亡2例,总有效率(有效+显效)93.5%;对照组显效24例,有效21例,无效13例,死亡7例,总有效率69.2%。结论:硝普钠在治疗急性心力衰竭中疗效明显,能有效改善临床症状,是血管扩张剂的首选。
Objective: To analyze the curative effect and safety of sodium nitroprusside in the treatment of acute heart failure, and to provide references for clinical application. Methods: The clinical data of 140 cases of acute heart failure admitted to Department of Cardiology of our hospital were selected. The patients were divided into control group of 75 cases (June 2010 ~ June 2011 admission, given conventional treatment); treatment group of 65 patients (July 2011 ~ June 2012 admitted to sodium nitroprusside adjuvant conventional treatment) Treatment for 7 days. Results: In the treatment group, 55 cases were markedly effective, 15 cases were effective, 3 cases were ineffective, and 2 cases died. The total effective rate (effective + effective) was 93.5%. In the control group, 24 cases were markedly effective, 21 cases were effective, 13 cases were ineffective, and 7 cases died. Effective 69.2%. Conclusion: Sodium nitroprusside is effective in treating acute heart failure and can effectively improve clinical symptoms. It is the first choice of vasodilators.